Dr. David S. Balle, MD

Dr. Balle practices at Grosse Pointe Dermatology Associates in Grosse Pointe, Michigan.

Dr. Balle's NPI, 1356334841, was assigned on August 30, 2005. Dr. Balle graduated from Wayne State University School Of Medicine in 1985. Dr. Balle holds Michigan license 4301406126.

Dr. Balle's primary practice is Grosse Pointe Dermatology Associates, at 16815 E Jefferson Ave, Grosse Pointe, MI 48230 in Wayne County. The practice phone is (313) 886-2600.

Dr. Balle's primary practice is Grosse Pointe Dermatology Associates in Grosse Pointe, Michigan. Dr. Balle is also affiliated with Corewell Health Beaumont Grosse Pointe Hospital. The medical group on file is Grosse Pointe Dermatology. Dmand AI also links Dr. Balle to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balle practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Balle's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Balle is board certified in member by the Alpha Omega Alpha Medical Honors Society. Dmand AI has Dr. Balle's licenses on file in 3 states: Michigan, New York and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Balle treats.

CMS data shows 3,874 Medicare services from Dr. Balle across 28 procedure codes in 2024, for 500 Medicare patients. Medicare paid $139,841 for them. Every service was in an office.

CMS counts 500 Medicare patients who saw Dr. Balle in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balle's median patient age at 68, with 54% women.

In 2024, Dr. Balle wrote 1,351 Medicare Part D claims for 499 patients. 96% of them were for generic drugs. CMS names the drug for 1,266 of them, across 30 drugs with 11 or more claims each, at $81,811 in total drug cost. In 2023, CMS named 1,014 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Balle for performance year 2024, reported as part of a group. Dr. Balle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,284 procedures of removal of skin lesions by Dr. Balle, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 274 general payments to Dr. Balle from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Galderma Laboratories, L.P. paid the most, $92,890.

Dmand AI lists 3 awards for Dr. Balle, most recently TOP DOC in 2023.

Dr. Balle graduated from Wayne State University School Of Medicine in 1985. Dr. Balle is a member of AAD and ASDS.

Dr. Balle is in network with 14 carriers, including Aetna, Health Alliance Plan and Priority Health. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.